Evidence map›Paper›PMID 40870079›Full record

ArticleMaterials (Basel, Switzerland)2025

Recyclable Wind Turbine Blades: A Life Cycle Analysis.

Navid Farazmandnia, Adrian Ilinca

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Navid FarazmandniaDepartment of Mechanical Engineering, École de Technologie Supérieure, Montreal, QC H3C 1K3, Canada.
Adrian IlincaDepartment of Mechanical Engineering, École de Technologie Supérieure, Montreal, QC H3C 1K3, Canada.ORCID 0000-0002-8236-2317

Funding

Natural Sciences and Engineering Research Council RGPIN-2025-04831
6 · The paper itself

Abstract

The shift towards renewable energy has highlighted the importance of sustainable practices in wind power development, particularly concerning the end-of-life (EoL) management of wind turbine blades. Conventional blades made from thermoset resins present significant recycling challenges due to their cross-linked structure, which often leads to landfill disposal or energy-intensive recycling processes. This study evaluates the environmental impacts of 45 m wind turbine blades using the Eco Audit approach across four primary life cycle stages: material production, manufacturing, transportation, and operation and maintenance. Six blade models with different fiber and resin configurations are assessed, focusing on a comparison between conventional thermoset resins and Elium, a newly developed liquid thermoplastic resin by Arkema. Elium offers promising recyclability options, including mechanical and chemical processes, which could substantially lower the environmental burden. Compared to composites made with thermoset resins, Elium-based blades demonstrate up to a 22.5% reduction in embodied energy and a 16% decrease in carbon footprint. Additionally, Elium's compatibility with existing manufacturing processes, room-temperature curing capability, and lower processing energy contribute to its industrial feasibility. Notably, the analysis reveals that the material production phase significantly contributes to the total environmental impact, accounting for up to 98% of the embodied energy and carbon footprint in certain blade models, underscoring the importance of selecting a more sustainable resin, such as Elium, from the outset to reduce the overall environmental load.

Indexed as

carbon footprintembodied energysimplified life cycle assessmentwind turbine blade materials

Identifiers

PMID40870079
PMCPMC12387391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.